Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [396]

Remissions following anti-CD22 CAR therapy in children with relapsed ALL

Dr Terry Fry - National Cancer Institute, Bethesda, USA

Remissions following anti-CD22 CAR therapy in children with relapsed ALL ( Dr Terry Fry - National Cancer Institute, Bethesda, USA )

Therapeutic targeting of childhood medulloblastoma

Dr Sheila Singh - McMaster University, Hamilton, Canada

Therapeutic targeting of childhood medulloblastoma ( Dr Sheila Singh - McMaster University, Hamilton, Canada )

Involving young people in cancer research

Lorna Fern - Teenage and Young Adult Clinical Studies Group, NCRI, UK

Involving young people in cancer research ( Lorna Fern - Teenage and Young Adult Clinical Studies Group, NCRI, UK )

Dabrafenib shows higher response and lower toxicity in paediatric brain cancer...

Dr Mark Kieran - Dana-Farber/Boston Children’s Cancer and Blood Disorders...

Dabrafenib shows higher response and lower toxicity in paediatric brain cancer trial ( Dr Mark Kieran - Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, USA )

A novel biomarker for paediatic tumours

Dr Kathleen Birley - UCL Institute of Child Health, London, UK

A novel biomarker for paediatic tumours ( Dr Kathleen Birley - UCL Institute of Child Health, London, UK )

Paediatric ALL with brain metastases

Dr Christina Halsey - University of Glasgow, Glasgow, UK

Paediatric ALL with brain metastases ( Dr Christina Halsey - University of Glasgow, Glasgow, UK )

miRNA screening for germ cell tumours

Dr Matthew Murray - University of Cambridge, Cambridge, UK

miRNA screening for germ cell tumours ( Dr Matthew Murray - University of Cambridge, Cambridge, UK )

ALK mutations in paediatric tumours

Dr Suzanne Turner - Cambridge University, Cambridge, UK

ALK mutations in paediatric tumours ( Dr Suzanne Turner - Cambridge University, Cambridge, UK )

Can we reduce exposure to risk factors associated with childhood leukaemia and...

Dr Mark Miller - UCSF, San Francisco, USA

Can we reduce exposure to risk factors associated with childhood leukaemia and other cancers? ( Dr Mark Miller - UCSF, San Francisco, USA )

Health outcomes and QOL in paediatric proton therapy

Dr Torunn Yock - Massachusetts General Hospital Cancer Center, Boston, USA

Health outcomes and QOL in paediatric proton therapy ( Dr Torunn Yock - Massachusetts General Hospital Cancer Center, Boston, USA )

Proton therapy for paediatric indications

Prof Roger Taylor - Swansea University Medical School, Swansea, UK

Proton therapy for paediatric indications ( Prof Roger Taylor - Swansea University Medical School, Swansea, UK )

Risk factors for childhood cancer: what are the challenges in research?

Dr Kurt Straif - IARC, Lyon, France

Risk factors for childhood cancer: what are the challenges in research? ( Dr Kurt Straif - IARC, Lyon, France )

More from ecancer